Summary of study ST000693

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000165. The data can be accessed directly via it's Project DOI: 10.21228/M8WS31 This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  |  Download all metabolite data  |  Perform analysis on untargeted data  |  Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data (Contains raw data)
Study IDST000693
Study TitleLanthanide-mineral induced alteration of bile acid metabolism in a murine model of steatohepatitis (part II)
Study TypeMS analysis
Study Summary120 mice (equal number of males and females) were randomized into 3 equal groups. One group is on a high-fat "Western-style" diet (HFWD) alone, a second group is on HFWD supplemented with lanthanides and calcium, and a third control group is supplemented with calcium alone. At study termination (18 months) we will harvest hepatocytes and colonic enterocytes for evaluation of epithelial gene expression patterns. We will also harvest cecal contents and feces for microbial profiling by 16S rRNA pyrosequencing. For this small pilot proposal, we wish to add an untargeted metabolomic analysis component. We will harvest liver (right medial lobe with gall bladder), serum, and feces. We will assay representative liver/gall bladder samples (8 from the HFWD group and 8 from the lanthanide/calcium supplemented group). Remaining liver samples and the serum and feces will be archived for future investigation. Liver is being targeted first since both steatohepatitis and hepatocellular carcinoma were seen in our previous study in mice on HFWD. Additionally, alterations of bile acid profiles and bile acid metabolism have been associated with both steatohepatitis and hepatic cancers.
Institute
University of Michigan
DepartmentBiomedical Research Core Facilities
LaboratoryMetabolomics core
Last NameKachman
First NameMaureen
Address6300 Brehm Tower, 1000 Wall Street, Ann Arbor, MI 48105-5714
Emailmkachman@med.umich.edu
Phone(734) 232-8175
Submit Date2017-06-19
Num Groups2
Total Subjects21
Raw Data AvailableYes
Raw Data File Type(s).wiff
Analysis Type DetailLC-MS
Release Date2017-12-06
Release Version1
Maureen Kachman Maureen Kachman
https://dx.doi.org/10.21228/M8WS31
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Project:

Project ID:PR000165
Project DOI:doi: 10.21228/M8WS31
Project Title:Tumor Suppression
Project Summary:Tumor suppression by diet in mice fed HFWD
Institute:University of Michigan
Department:Animal Medicine
Laboratory:Bergin Lab
Last Name:Bergin
First Name:Ingrid
Address:Ann Arbor, MI
Email:ingridbe@med.umich.edu
Phone:734-936-1701

Subject:

Subject ID:SU000716
Subject Type:Mouse
Subject Species:Mus musculus
Taxonomy ID:10090
Species Group:Mammal

Factors:

Subject type: Mouse; Subject species: Mus musculus (Factor headings shown in green)

mb_sample_id local_sample_id DIET
SA039244S00020137-
SA039245S00016588-
SA039246S00015184HFWD
SA039247S00015175HFWD
SA039248S00015183HFWD
SA039249S00015182HFWD
SA039250S00015177HFWD
SA039251S00015176HFWD
SA039252S00015179HFWD
SA039253S00015178HFWD
SA039254S00015180HFWD
SA039255S00015181HFWD
SA039256S00015192HFWD + La/Ca
SA039257S00015193HFWD + La/Ca
SA039258S00015191HFWD + La/Ca
SA039259S00015185HFWD + La/Ca
SA039260S00015186HFWD + La/Ca
SA039261S00015187HFWD + La/Ca
SA039262S00015188HFWD + La/Ca
SA039263S00015189HFWD + La/Ca
SA039264S00015190HFWD + La/Ca
Showing results 1 to 21 of 21

Collection:

Collection ID:CO000710
Collection Summary:-

Treatment:

Treatment ID:TR000730
Treatment Summary:-

Sample Preparation:

Sampleprep ID:SP000723
Sampleprep Summary:-
Sampleprep Protocol Filename:A003_-_Untargeted_Metabolomics.pdf

Combined analysis:

Analysis ID AN001071 AN001072
Analysis type MS MS
Chromatography type Reversed phase Reversed phase
Chromatography system Agilent Agilent
Column Waters Acquity HSS T3 (50 x 2.1mm, 1.8um) Waters Acquity HSS T3 (50 x 2.1mm, 1.8um)
MS Type ESI ESI
MS instrument type QTOF QTOF
MS instrument name Agilent 6530 QTOF Agilent 6530 QTOF
Ion Mode NEGATIVE POSITIVE
Units peak area peak area

Chromatography:

Chromatography ID:CH000756
Instrument Name:Agilent
Column Name:Waters Acquity HSS T3 (50 x 2.1mm, 1.8um)
Chromatography Type:Reversed phase

MS:

MS ID:MS000966
Analysis ID:AN001071
Instrument Name:Agilent 6530 QTOF
Instrument Type:QTOF
MS Type:ESI
Ion Mode:NEGATIVE
  
MS ID:MS000967
Analysis ID:AN001072
Instrument Name:Agilent 6530 QTOF
Instrument Type:QTOF
MS Type:ESI
Ion Mode:POSITIVE
  logo